In this video, Dr. Kalyanam, President of Sabinsa's R&D, talks you through the latest findings on Curcumin C3 Complex. He describes in detail, with referenced publications, the importance of systemic bioavailability and gastrointestinal availability.
Videos
Curcumin C3 Complex®: The Whole Picture & The Whole Truth
In this video, Dr. Kalyanam, President of Sabinsa's R&D, talks you through the latest findings on Curcumin C3 Complex. He describes in detail, with referenced publications, the importance of systemic bioavailability and gastrointestinal availability.
More Videos by Sabinsa Corporation
-
Videos
-
Videos
-
Videos
-
Videos
More Content From Sabinsa Corporation
-
BioPerine Increases Ingredient Bioavailability
BioPerine® has been widely used to enhance the bioavailability of several dietary supplement ingredients and requires a very low dosage of 5mg per serving.White Papers / Tech Papers Released on 06.20.2023
-
The Ingredients Driving Nutricosmetic Trends
Download to learn more about the latest nutricosmetics market trends and the specific ingredients driving them.Sponsored Content Released on 04.11.2023
-
Supplier Insights: Sabinsa Strengthens Supply Chains from the Ground Up
Shaheen Majeed, President Worldwide, Sabinsa, tells how the company is navigating uncertain times, the importance of IP/innovation, and plans for the future.Sponsored Content Released on 11.10.2020
-
New Diabetic Research on Sabinsa’s Curcumin C3 Complex ® and BioPerine Combination Published
...News Releases Released on 10.08.2018
-
Research on Curcumin’s Positive Effects on Microbiome Published
Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to ResearchersNews Releases Released on 09.17.2018
-
TUFTS - TOHOKU STUDY ON CURCUMIN + PIPERINE COMBINATION
VERIFIES SABINSA'S RESEARCH ON SYNERGISTIC PROPERTIESNews Releases Released on 04.03.2018
-
SABINSA’S CURCUMIN C3 COMPLEX® WITH BIOPERINE® SHOWS PROTECTIVE ROLE IN LIPID PROFILE MODIFICATION
IN TYPE 2 DIABETES IN PUBLISHED STUDYNews Releases Released on 06.19.2017
-
SABINSA’S CURCUMIN C3 COMPLEX® STUDIED FOR ANTIOXIDANT EFFECT IN DIABETES PATIENTS
RANDOMIZED, CONTROLLED STUDY PUBLISHED IN INFLAMMOPHARMACOLOGYNews Releases Released on 02.06.2017
-
UNIVERSITY RESEARCH COMPARING FIVE CURCUMIN BRANDS IDENTIFIES SABINSA’S CURCUMIN C3 COMPLEX
AS THE MOST ACTIVE FORMNews Releases Released on 11.16.2016
-
SABINSA’S CURCUMIN C3 COMPLEX® IN COMBINATION WITH OMEGA-‐3s FOUND TO HAVE SYNERGISTIC EFFECT
...News Releases Released on 10.26.2016
-
APPROVAL FOR NEW HEALTH CLAIMS ON CURCUMIN C3 COMPLEX® AND CURCUMIN C3 REDUCT® IN CANADA
INCLUDES FIRST HEALTH CLAIM FOR A CURCUMIN METABOLITENews Releases Released on 09.20.2016
-
SABINSA ANNOUNCES CURCUMIN TESTING PROGRAM TO ASSURE AUTHENTICITY IN CAMPAIGN
TO ELIMINATE ADULTERATION WITH SYNTHETICSNews Releases Released on 06.13.2016
-
METABOLIC SYNDROME STUDY ON SABINSA’S CURCUMIN C3 COMPLEX® HONORED
WITH UNIVERSITY RESEARCH OF THE YEAR AWARDNews Releases Released on 05.18.2016
-
CURRY POWDER TO CLINICAL SIGNIFICANCE
New Book Provides a Comprehensive Understanding of Curcumin & Studies on Curcumin C3 Complex®News Releases Released on 12.10.2015
-
SABINSA’S CURCUMIN C3 COMPLEX ® TO BE SAFE ADJUNCT TO, AND ENHANCE EFFICACY OF, FOLFOX CHEMOTHERAPY
UK STUDY SHOWSNews Releases Released on 06.16.2015
